Total Payments
$37,302
2024 Payments
$12,181
Companies
16
Transactions
149
Medicare Patients
1,646
Medicare Billing
$186,234
Payment Breakdown by Category
Other$30,722 (82.4%)
Food & Beverage$4,221 (11.3%)
Travel$2,359 (6.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $30,722 | 15 | 82.4% |
| Food and Beverage | $4,221 | 119 | 11.3% |
| Travel and Lodging | $2,359 | 15 | 6.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| IDORSIA PHARMACEUTICALS US INC | $33,483 | 50 | $0 (2024) |
| Inspire Medical Systems, Inc. | $1,326 | 5 | $0 (2023) |
| JAZZ PHARMACEUTICALS INC. | $962.25 | 48 | $0 (2024) |
| HARMONY BIOSCIENCES LLC | $461.27 | 14 | $0 (2024) |
| Philips Electronics North America Corporation | $409.25 | 13 | $0 (2023) |
| ZOLL Respicardia, Inc. | $131.15 | 1 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $129.74 | 1 | $0 (2017) |
| Avadel CNS Pharmaceuticals, LLC | $116.58 | 2 | $0 (2024) |
| AbbVie Inc. | $80.17 | 4 | $0 (2021) |
| Axsome Therapeutics, Inc. | $78.74 | 4 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $12,181 | 30 | IDORSIA PHARMACEUTICALS US INC ($11,893) |
| 2023 | $19,664 | 31 | IDORSIA PHARMACEUTICALS US INC ($19,375) |
| 2022 | $3,268 | 39 | IDORSIA PHARMACEUTICALS US INC ($2,216) |
| 2021 | $1,554 | 32 | Inspire Medical Systems, Inc. ($765.29) |
| 2020 | $238.52 | 11 | Jazz Pharmaceuticals Inc. ($165.31) |
| 2019 | $205.87 | 4 | JAZZ PHARMACEUTICALS INC. ($118.46) |
| 2018 | $60.30 | 1 | Philips Electronics North America Corporation ($60.30) |
| 2017 | $129.74 | 1 | AstraZeneca Pharmaceuticals LP ($129.74) |
All Payment Transactions
149 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/06/2024 | Harmony Biosciences Llc | WAKIX (Drug) | Food and Beverage | Cash or cash equivalent | $28.43 | General |
| Category: Narcoplepsy | ||||||
| 11/27/2024 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Travel and Lodging | In-kind items and services | $162.14 | General |
| Category: Insomnia | ||||||
| 11/25/2024 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,392.50 | General |
| Category: Insomnia | ||||||
| 11/21/2024 | Avadel CNS Pharmaceuticals, LLC | LUMRYZ (Drug) | Food and Beverage | In-kind items and services | $97.38 | General |
| Category: CENTRAL NERVOUS SYSTEM CNS NEUROLOGY | ||||||
| 11/20/2024 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $84.32 | General |
| Category: Insomnia | ||||||
| 11/01/2024 | JAZZ PHARMACEUTICALS INC. | XYWAV (Drug) | Food and Beverage | In-kind items and services | $38.28 | General |
| Category: NEUROLOGY | ||||||
| 10/21/2024 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,262.50 | General |
| Category: Insomnia | ||||||
| 10/21/2024 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Travel and Lodging | In-kind items and services | $126.43 | General |
| Category: Insomnia | ||||||
| 10/21/2024 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $41.08 | General |
| Category: Insomnia | ||||||
| 10/21/2024 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Travel and Lodging | In-kind items and services | $30.00 | General |
| Category: Insomnia | ||||||
| 10/21/2024 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Travel and Lodging | In-kind items and services | $20.10 | General |
| Category: Insomnia | ||||||
| 10/21/2024 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $20.03 | General |
| Category: Insomnia | ||||||
| 10/11/2024 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Travel and Lodging | In-kind items and services | $166.70 | General |
| Category: Insomnia | ||||||
| 10/10/2024 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $90.17 | General |
| Category: Insomnia | ||||||
| 09/25/2024 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,957.50 | General |
| Category: Insomnia | ||||||
| 09/24/2024 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Travel and Lodging | In-kind items and services | $378.97 | General |
| Category: Insomnia | ||||||
| 09/24/2024 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Travel and Lodging | In-kind items and services | $228.98 | General |
| Category: Insomnia | ||||||
| 09/20/2024 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $115.93 | General |
| Category: Insomnia | ||||||
| 07/19/2024 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $21.61 | General |
| Category: Insomnia | ||||||
| 07/08/2024 | Axsome Therapeutics, Inc. | Sunosi (Drug) | Food and Beverage | In-kind items and services | $23.79 | General |
| Category: Neurology | ||||||
| 07/03/2024 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $652.50 | General |
| Category: Insomnia | ||||||
| 06/26/2024 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $24.29 | General |
| Category: Insomnia | ||||||
| 05/28/2024 | HARMONY BIOSCIENCES LLC | WAKIX (Drug) | Food and Beverage | Cash or cash equivalent | $25.19 | General |
| Category: Narcoplepsy | ||||||
| 03/19/2024 | JAZZ PHARMACEUTICALS INC. | XYWAV (Drug) | Food and Beverage | In-kind items and services | $24.35 | General |
| Category: NEUROLOGY | ||||||
| 03/11/2024 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,957.50 | General |
| Category: Insomnia | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 216 | 252 | $44,097 | $23,297 |
| 2022 | 4 | 258 | 316 | $57,320 | $31,754 |
| 2021 | 5 | 399 | 420 | $129,280 | $38,917 |
| 2020 | 9 | 773 | 830 | $298,559 | $92,266 |
Total Patients
1,646
Total Services
1,818
Medicare Billing
$186,234
Procedure Codes
23
All Medicare Procedures & Services
23 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 92 | 125 | $16,875 | $10,793 | 64.0% |
| 95800 | Sleep study including heart rate, breathing, and sleep time | Office | 2023 | 65 | 68 | $15,817 | $6,408 | 40.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 29 | 29 | $5,655 | $2,873 | 50.8% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 16 | 16 | $4,000 | $2,424 | 60.6% |
| 95808 | Sleep study in sleep lab | Office | 2023 | 14 | 14 | $1,750 | $799.52 | 45.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 93 | 149 | $20,115 | $13,386 | 66.5% |
| 95800 | Sleep study including heart rate, breathing, and sleep time | Office | 2022 | 81 | 83 | $19,505 | $8,965 | 46.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 60 | 60 | $11,700 | $5,794 | 49.5% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 24 | 24 | $6,000 | $3,609 | 60.2% |
| 95800 | Study of sleep patterns, including sleep time | Office | 2021 | 209 | 213 | $94,290 | $22,583 | 24.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 68 | 81 | $12,930 | $6,769 | 52.4% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 54 | 54 | $13,065 | $5,711 | 43.7% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 55 | 59 | $6,785 | $2,990 | 44.1% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 13 | 13 | $2,210 | $862.97 | 39.0% |
| 95800 | Study of sleep patterns | Office | 2020 | 301 | 304 | $151,875 | $33,258 | 21.9% |
| 95811 | Sleep monitoring of patient (6 years or older) in sleep lab with continued pressured respiratory assistance by mask or breathing tube | Office | 2020 | 37 | 37 | $40,700 | $16,305 | 40.1% |
| 95810 | Sleep monitoring of patient (6 years or older) in sleep lab | Office | 2020 | 32 | 32 | $35,200 | $13,213 | 37.5% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 187 | 219 | $25,126 | $10,774 | 42.9% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 104 | 104 | $27,040 | $10,481 | 38.8% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 70 | 76 | $12,920 | $5,528 | 42.8% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 17 | 18 | $2,304 | $1,018 | 44.2% |
| 99457 | Remote physiologic monitoring treatment management services, health care professional time in a calendar month requiring interactive communication with the patient/caregiver; first 20 minutes | Office | 2020 | 13 | 28 | $1,354 | $915.11 | 67.6% |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | Office | 2020 | 12 | 12 | $2,040 | $773.16 | 37.9% |
About Dr. Bijoy John, MD
Dr. Bijoy John, MD is a Critical Care Medicine healthcare provider based in Brentwood, Tennessee. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/09/2005. The National Provider Identifier (NPI) number assigned to this provider is 1467456228.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Bijoy John, MD has received a total of $37,302 in payments from pharmaceutical and medical device companies, with $12,181 received in 2024. These payments were reported across 149 transactions from 16 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($30,722).
As a Medicare-enrolled provider, John has provided services to 1,646 Medicare beneficiaries, totaling 1,818 services with total Medicare billing of $186,234. Data is available for 4 years (2020–2023), covering 23 distinct procedure/service records.
Ad
Practice Information
- Specialty Critical Care Medicine
- Other Specialties Pulmonary Disease, Sleep Medicine
- Location Brentwood, TN
- Active Since 06/09/2005
- Last Updated 03/01/2024
- Taxonomy Code 207RC0200X
- Entity Type Individual
- NPI Number 1467456228
Products in Payments
- QUVIVIQ (Drug) $33,483
- Inspire Upper Airway Stimulation System (Device) $1,165
- XYWAV (Drug) $431.08
- SUNOSI (Drug) $409.92
- Wakix (Drug) $392.78
- INSPIRE (Device) $161.08
- remede System (Device) $131.15
- BEVESPI AEROSPHERE (Drug) $129.74
- XYREM (Drug) $121.25
- LUMRYZ (Drug) $116.58
- Home Sleep Testing (Device) $111.68
- (6364) Alice NightOne Sales (Device) $88.43
- VRAYLAR (Drug) $80.17
- Sunosi (Drug) $78.74
- (8211) DreamStation Cpap Auto Core (Device) $68.71
- WAKIX (Drug) $68.49
- (8744) Trilogy Evo (Device) $51.75
- (0147) Home Sleep Testing (Device) $37.56
- BELSOMRA (Drug) $21.38
- Aimovig (Biological) $19.80
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.